Biomarkers for Diabetes

Biomarker”, are called “molecular marker” or a “signature molecule”. These viewed as direct or indirect markers of the extent of disease as they lay outside in a casual way. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored. Cases over the past two decades have yielded sample sets, mostly blood products and urine from a large category of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

August 20-21, 2018

28th World Congress on Diabetes, Obesity & Heart

Tokyo, Japan
September 03-04, 2018

2nd International Conference on Thyroid and Pregnancy

Auckland, New Zealand
September 3-4, 2018

11th World Congress on Endocrinology and Metabolic Disorders

Auckland, New Zealand
September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

March 28-29, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 16-17, 2019

2nd Global Meeting on Diabetes and Endocrinology

Abu Dhabi, UAE

28th European Diabetes Congress

June 10-11, 2019 | Edinburgh, Scotland
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in